Heart Rate Variability Biofeedback Does Not Substitute for Asthma Steroid Controller Medication

Area of Science:

• Pulmonary Medicine
• Behavioral Medicine
• Respiratory Health

Background:

• Previous studies suggested therapeutic effects of heart rate variability biofeedback (HRVB) for asthma.
• It remains unclear if HRVB can substitute for controller or rescue asthma medications or impact airway inflammation.

Purpose of the Study:

• To investigate if HRVB can replace controller/rescue asthma medication.
• To determine HRVB's effect on airway inflammation.
• To compare HRVB with EEG alpha biofeedback in mild/moderate asthma patients.

Main Methods:

• Sixty-eight steroid-naïve participants with mild/moderate asthma underwent 3 months of HRVB or EEG alpha biofeedback with music and paced breathing.
• All participants received 1 month of intensive asthma education prior to randomization.
• Outcomes included methacholine challenge test (MCT), asthma symptoms, quality of life (AQOL), and exhaled nitric oxide (eNO).

Main Results:

• Both HRVB and EEG+ significantly improved MCT, asthma symptoms, and AQOL, with effects comparable to enhanced placebo.
• HRVB group showed a significant decrease in exhaled nitric oxide, reaching 81% of the effect seen with inhaled budesonide.
• Neither biofeedback technique normalized pulmonary function, indicating they are not replacements for controller medications.

Conclusions:

• HRVB should not be considered an alternative to standard asthma controller medications like inhaled steroids.
• Both biofeedback conditions demonstrated beneficial effects, suggesting potential complementary roles in asthma management.
• Further research is warranted to explore the mechanisms and optimize the application of biofeedback in asthma care.